Form 4: Precigen's Chief Legal Officer, Donald P. Lehr, Reports Acquisition of Restricted Stock Units

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reports the acquisition of 165,468 Restricted Stock Units (RSUs) on April 17, 2025, vesting fully on May 16, 2025.

Summary

• On April 18, 2025, a Form 4 filing was submitted to the SEC by Donald P. Lehr, Chief Legal Officer of Precigen, Inc.
• The filing reports a transaction that occurred on April 17, 2025, where Mr. Lehr acquired 165,468 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Precigen common stock.
• These RSUs are scheduled to vest in full on May 16, 2025.
• Following the reported transaction, Mr. Lehr beneficially owns 165,468 shares of Precigen common stock through these RSUs.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding executive compensation, so the sentiment is neutral.

Positives

• The acquisition of RSUs by a key executive could be interpreted as a sign of confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a standard SEC filing related to executive compensation and is common in the biotechnology industry.

Stakeholder Impact

• The granting of RSUs to a key executive may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Precigen, Donald P. Lehr, Restricted Stock Units, RSUs, Form 4, Beneficial Ownership, Chief Legal Officer, PGEN